Setback for amendment to IVD Directive
This article was originally published in RAJ Devices
The EU Council of Ministers has published a formal decision explicitly rejecting the proposed amendment of the In Vitro Diagnostics Directive to include vCJD assays in the Annex II, list A, one of the highest risk classes in the directive1.
You may also be interested in...
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.